Neuroscience_in_psychiatry - Articles - Page 2

Nuedexta for Pseudobulbar Affect

January 1, 2012

Steve Balt, MD Research fellow, Addiction Pharmacology Research Laboratory, California Pacific Medical Center Dr. Balt discloses that his spouse is employed as a sales representative for Bristol Myers Squibb. Daniel Carlat, MD

Editor-in-Chief, Publisher, The Carlat Report.

Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.

Nuedexta is a combination of dextromethorphan (DM) and quinidine sulfate. You might reasonably ask why these two agents would have ever been considered as a treatment for PBA.

The Neurobiology of Trauma

November 1, 2011

If a child has been neglected, abused, subjected to domestic violence, or developed an attachment disorder from parents who may not have been abusive but angry, critical, reactive, and in other ways frightening to the child, the child’s mind and body have, within a relatively short time, become adapted to those conditions.

Neurofeedback as a Treatment for ADHD

January 1, 2011

Daniel Carlat, MD.

Neurofeedback, also known as “EEG biofeedback,” has been around for a long time, but its history is checkered.

Treating Headaches in Psychiatry

September 1, 2009

Daniel Carlat, MD

We know that headaches are common in the general population, but they are particularly common among patients with psychiatric problems. According to one review, (Pompili M et al., J Headache Pain 2009; 10(4):283-290) patients with depression have a 46% lifetime prevalence of migraine, while bipolar patients have a 51% prevalence. Patients with migraines have triple the risk of developing depression than patients without migraines.

History of Neurotransmitters in Psychiatry

July 1, 2006

Samuel H. Barondes, MD

Samuel H. Barondes, MD Jeanne and Sanford Robertson Professor of Psychiatry Director of the Center for Neurobiology and Psychiatry University of California, San Francisco School of Medicine Author, Molecules and Mental Illness, Mood Genes, and Better Than Prozac Dr. Barondes has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.

Dr. Barondes, you were a researcher at the NIH during the period when the earliest research on neurotransmitters and antidepressants was conducted. What happened while you were there?